Healthcare provider profile · identity verified

Jennifer S Schroeder, MD

Allopathic & Osteopathic Physicians|Family Medicine · MOUNT STERLING, IL · NPI 1003889957

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jennifer S Schroeder, MD received $105.79 in general payments during 2025 across 4 reported records.

ABBVIE INC. accounted for 63.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Vraylar by this doctor in 2024.

Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$105.79

4 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$67.25	63.6%	3	2025
Lundbeck LLC	Unresolved — no canonical attribution shown	$38.54	36.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$67.25	3
Education	$38.54	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$67.25	3	2025
Source payment records 2025-01-28 · ABBVIE INC. · $29.52 · Open Payments source 2025-04-08 · ABBVIE INC. · $14.99 · Open Payments source 2025-04-30 · ABBVIE INC. · $22.74 · Open Payments source
REXULTI Normalized: rexulti	Drug	Lundbeck LLC	$38.54	1	2025
Source payment records 2025-01-14 · Lundbeck LLC · $38.54 · Open Payments source
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$14.99	1	2025
Source payment records 2025-04-08 · ABBVIE INC. · $14.99 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	22 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	49	11
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS
Lundbeck LLC Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986	Rexulti · 2024 Exact normalized brand match · 1 Part D row	22	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1347	248
Levothyroxine Sodium	Levothyroxine Sodium	1123	177
Amlodipine Besylate	Amlodipine Besylate	1020	170
Lisinopril	Lisinopril	962	191
Omeprazole	Omeprazole	961	167
Metoprolol Succinate	Metoprolol Succinate	897	147
Gabapentin	Gabapentin	784	125
Furosemide	Furosemide	749	129
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	641	100
Pantoprazole Sodium	Pantoprazole Sodium	640	136
Losartan Potassium	Losartan Potassium	603	115
Metformin Hcl	Metformin Hcl	562	94
Tamsulosin Hcl	Tamsulosin Hcl	518	96
Escitalopram Oxalate	Escitalopram Oxalate	496	86
Hydrochlorothiazide	Hydrochlorothiazide	481	91
Tramadol Hcl	Tramadol Hcl	479	103
Metoprolol Tartrate	Metoprolol Tartrate	477	78
Montelukast Sodium	Montelukast Sodium	472	87
Eliquis	Apixaban	442	58
Potassium Chloride	Potassium Chloride	421	78
Clopidogrel	Clopidogrel Bisulfate	389	61
Donepezil Hcl	Donepezil Hcl	384	53
Prednisone	Prednisone	355	201
Pravastatin Sodium	Pravastatin Sodium	332	64
Citalopram Hbr	Citalopram Hydrobromide	320	52
Duloxetine Hcl	Duloxetine Hcl	312	56
Meloxicam	Meloxicam	308	50
Sertraline Hcl	Sertraline Hcl	286	48
Simvastatin	Simvastatin	279	48
Pregabalin	Pregabalin	264	40
Allopurinol	Allopurinol	257	44
Albuterol Sulfate Hfa	Albuterol Sulfate	250	86
Jardiance	Empagliflozin	249	33
Memantine Hcl	Memantine Hcl	248	31
Famotidine	Famotidine	244	42
Rosuvastatin Calcium	Rosuvastatin Calcium	240	51
Carvedilol	Carvedilol	237	57
Trazodone Hcl	Trazodone Hcl	234	50
Buspirone Hcl	Buspirone Hcl	232	48
Lorazepam	Lorazepam	229	41
Fluticasone Propionate	Fluticasone Propionate	219	57
Alprazolam	Alprazolam	211	33
Xarelto	Rivaroxaban	204	22
Topiramate	Topiramate	192	27
Metformin Hcl Er	Metformin Hcl	188	39
Warfarin Sodium	Warfarin Sodium	187	28
Tizanidine Hcl	Tizanidine Hcl	183	43
Pioglitazone Hcl	Pioglitazone Hcl	172	32
Atenolol	Atenolol	167	30
Quetiapine Fumarate	Quetiapine Fumarate	166	25
Celecoxib	Celecoxib	163	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	163	35
Oxybutynin Chloride Er	Oxybutynin Chloride	161	29
Venlafaxine Hcl Er	Venlafaxine Hcl	156	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	151	38
Glipizide Er	Glipizide	149	30
Myrbetriq	Mirabegron	145	12
Januvia	Sitagliptin Phosphate	142	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	141	22
Fluoxetine Hcl	Fluoxetine Hcl	140	33
Spironolactone	Spironolactone	138	22
Mirtazapine	Mirtazapine	131	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	131	27
Olanzapine	Olanzapine	126	15
Glipizide	Glipizide	119	19
Baclofen	Baclofen	118	21
Oxycodone Hcl	Oxycodone Hcl	115	19
Ezetimibe	Ezetimibe	109	19
Bupropion Xl	Bupropion Hcl	108	24
Lamotrigine	Lamotrigine	108	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	107	17
Finasteride	Finasteride	106	17
Trulicity	Dulaglutide	106	15
Oxybutynin Chloride	Oxybutynin Chloride	102	18
Levetiracetam	Levetiracetam	101	13
Ozempic	Semaglutide	99	22
Lovastatin	Lovastatin	98	19
Dicyclomine Hcl	Dicyclomine Hcl	96	17
Amitriptyline Hcl	Amitriptyline Hcl	95	14
Torsemide	Torsemide	95	18
Cephalexin	Cephalexin	93	58
Latanoprost	Latanoprost	92	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	91	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	89	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	20
Ondansetron Odt	Ondansetron	88	37
Clonazepam	Clonazepam	85	17
Farxiga	Dapagliflozin Propanediol	85	11
Paroxetine Hcl	Paroxetine Hcl	84	20
Ropinirole Hcl	Ropinirole Hcl	83	15
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	80	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	80	11
Ibuprofen	Ibuprofen	77	12
Hydralazine Hcl	Hydralazine Hcl	73	12
Aripiprazole	Aripiprazole	72	16
Ventolin Hfa	Albuterol Sulfate	72	21
Diclofenac Sodium	Diclofenac Sodium	68	19
Chlorthalidone	Chlorthalidone	67	15
Combivent Respimat	Ipratropium/Albuterol Sulfate	65	suppressed
Timolol Maleate	Timolol Maleate	65	13
Enalapril Maleate	Enalapril Maleate	64	13
Divalproex Sodium	Divalproex Sodium	60	suppressed
Levofloxacin	Levofloxacin	60	46
Carbidopa-Levodopa	Carbidopa/Levodopa	59	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	11
Risperidone	Risperidone	59	12
Breo Ellipta	Fluticasone/Vilanterol	58	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	58	22
Memantine Hcl Er	Memantine Hcl	57	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	56	28
Cefuroxime	Cefuroxime Axetil	55	35
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	55	31
Amiodarone Hcl	Amiodarone Hcl	54	12
Ondansetron Hcl	Ondansetron Hcl	54	30
Naproxen	Naproxen	52	suppressed
Bupropion Hcl	Bupropion Hcl	50	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	50	suppressed
Estradiol	Estradiol	49	13
Primidone	Primidone	49	suppressed
Synthroid	Levothyroxine Sodium	49	11
Doxazosin Mesylate	Doxazosin Mesylate	48	suppressed
Propranolol Hcl	Propranolol Hcl	48	14
Zolpidem Tartrate	Zolpidem Tartrate	46	16
Fenofibrate	Fenofibrate	45	11
Meclizine Hcl	Meclizine Hcl	45	17
Clonidine Hcl	Clonidine Hcl	44	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	43	suppressed
Fentanyl	Fentanyl	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	31
Terazosin Hcl	Terazosin Hcl	40	suppressed
Benazepril Hcl	Benazepril Hcl	39	suppressed
Bupropion Hcl Sr	Bupropion Hcl	39	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	39	suppressed
Incruse Ellipta	Umeclidinium Bromide	38	suppressed
Temazepam	Temazepam	38	suppressed
Nifedipine Er	Nifedipine	37	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	36	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	36	suppressed
Tradjenta	Linagliptin	35	suppressed
Verapamil Er	Verapamil Hcl	35	suppressed
Nystatin	Nystatin	33	23
Spiriva Handihaler	Tiotropium Bromide	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Diazepam	Diazepam	32	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	32	suppressed
Brilinta	Ticagrelor	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	11
Digoxin	Digoxin	29	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	15
Methotrexate	Methotrexate Sodium	29	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	29	suppressed
Varenicline Tartrate	Varenicline Tartrate	28	suppressed
Naltrexone Hcl	Naltrexone Hcl	27	suppressed
Novolog	Insulin Aspart	27	suppressed
Oxcarbazepine	Oxcarbazepine	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Nitroglycerin	Nitroglycerin	26	22
Novolog Flexpen	Insulin Aspart	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Fluconazole	Fluconazole	25	22
Linzess	Linaclotide	25	suppressed
Modafinil	Modafinil	25	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	25	21
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	25	suppressed
Vraylar	Cariprazine Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Lidocaine	Lidocaine	24	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	23	suppressed
Klor-Con M20	Potassium Chloride	23	11
Loperamide	Loperamide Hcl	23	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	22	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	22	suppressed
Cilostazol	Cilostazol	22	suppressed
Imiquimod	Imiquimod	22	suppressed
Megestrol Acetate	Megestrol Acetate	22	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	22	suppressed
Rexulti	Brexpiprazole	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	11
Dutasteride	Dutasteride	21	suppressed
Enulose	Lactulose	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Morphine Sulfate	Morphine Sulfate	21	16
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Lidocaine Hcl	Lidocaine Hcl	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	20	suppressed
Sotalol	Sotalol Hcl	20	suppressed
Zonisamide	Zonisamide	20	suppressed
Indapamide	Indapamide	19	suppressed
Lacosamide	Lacosamide	19	suppressed
Mirabegron Er	Mirabegron	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Amoxicillin	Amoxicillin	18	15
Atomoxetine Hcl	Atomoxetine Hcl	18	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Methylprednisolone	Methylprednisolone	18	15
Nystop	Nystatin	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	12
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Elmiron	Pentosan Polysulfate Sodium	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Solu-Medrol	Methylprednisolone Sod Succ/Pf	16	13
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Trintellix	Vortioxetine Hydrobromide	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Xtampza Er	Oxycodone Myristate	16	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Tranylcypromine Sulfate	Tranylcypromine Sulfate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Clozapine	Clozapine	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Invokana	Canagliflozin	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Zafirlukast	Zafirlukast	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Caplyta	Lumateperone Tosylate	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Fiasp	Insulin Aspart (Niacinamide)	13	suppressed
Guanfacine Hcl	Guanfacine Hcl	13	suppressed
Invega Sustenna	Paliperidone Palmitate	13	suppressed
Lurasidone Hcl	Lurasidone Hcl	13	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	13	suppressed
Piroxicam	Piroxicam	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Fosinopril Sodium	Fosinopril Sodium	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Trandolapril	Trandolapril	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Colchicine	Colchicine	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Dofetilide	Dofetilide	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Glatopa	Glatiramer Acetate	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Metolazone	Metolazone	11	suppressed
Metronidazole	Metronidazole	11	11
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Valsartan	Valsartan	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$105.79 · 4 records	ABBVIE INC.	QULIPTA, REXULTI, UBRELVY	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error